AMED - Amedisys, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
108.34
-3.89 (-3.47%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close112.23
Open110.46
Bid0.00 x 800
Ask0.00 x 800
Day's Range107.57 - 112.11
52 Week Range71.74 - 140.91
Volume456,217
Avg. Volume541,504
Market Cap3.472B
Beta (3Y Monthly)1.21
PE Ratio (TTM)29.17
EPS (TTM)3.71
Earnings DateJul 29, 2019 - Aug 2, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est136.00
Trade prices are not sourced from all markets
  • Here is Why Growth Investors Should Buy Amedisys (AMED) Now
    Zacks5 days ago

    Here is Why Growth Investors Should Buy Amedisys (AMED) Now

    Amedisys (AMED) could produce exceptional returns because of its solid growth attributes.

  • Do Directors Own Amedisys, Inc. (NASDAQ:AMED) Shares?
    Simply Wall St.5 days ago

    Do Directors Own Amedisys, Inc. (NASDAQ:AMED) Shares?

    The big shareholder groups in Amedisys, Inc. (NASDAQ:AMED) have power over the company. Large companies usually have...

  • GlobeNewswire6 days ago

    Amedisys to Present at the 2019 RBC Capital Markets Healthcare Conference

    Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the 2019 RBC Capital Markets Healthcare Conference in New York City, NY on Tuesday, May 21, 2019. Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care.

  • Markit6 days ago

    See what the IHS Markit Score report has to say about Amedisys Inc.

    Amedisys Inc NASDAQ/NGS:AMEDView full report here! Summary * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is low for AMED with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold AMED had net inflows of $310 million over the last one-month. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Zacks.com featured highlights include: Exantas Capital, Lamb Weston, Bristol-Myers Squibb, Amedisys and Computer Programs and Systems
    Zacks11 days ago

    Zacks.com featured highlights include: Exantas Capital, Lamb Weston, Bristol-Myers Squibb, Amedisys and Computer Programs and Systems

    Zacks.com featured highlights include: Exantas Capital, Lamb Weston, Bristol-Myers Squibb, Amedisys and Computer Programs and Systems

  • GlobeNewswire12 days ago

    Media Statement from Amedisys Commending the Home Health Payment Innovation Act of 2019

    BATON ROUGE, La., May 08, 2019 -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care company, commends bipartisan legislation.

  • GlobeNewswire12 days ago

    Amedisys to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference

    Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the Bank of America Merrill Lynch 2019 Healthcare Conference in Las Vegas, NV on Tuesday, May 14, 2019. Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care.

  • 5 Stocks With Upgraded Broker Ratings Worth Betting on Now
    Zacks12 days ago

    5 Stocks With Upgraded Broker Ratings Worth Betting on Now

    Brokers have more understanding of fundamentals of a company, and also about the overall economy. So, following broker advice is a wise decision.

  • Thomson Reuters StreetEvents13 days ago

    Edited Transcript of AMED earnings conference call or presentation 1-May-19 3:00pm GMT

    Q1 2019 Amedisys Inc Earnings Call

  • GlobeNewswire14 days ago

    Amedisys Celebrates More Than 7,000 Nurses During National Nurses Week

    Amedisys, Inc. (AMED), one of the nation’s leading home healthcare, hospice and personal care companies, celebrates National Nurses Week by honoring more than 7,000 nurses who call the company home. National Nurses Week begins each year on May 6 and ends on May 12, Florence Nightingale’s birthday. Amedisys is proud to recognize and applaud the home health, hospice and personal care nurses who provide compassionate, clinically distinct care throughout the 38 states we serve.

  • Why You Should Keep An Eye On These Leading Health Care Stocks
    Investor's Business Daily14 days ago

    Why You Should Keep An Eye On These Leading Health Care Stocks

    The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.

  • Amedisys (AMED) Tops Earnings and Revenue Estimates in Q1
    Zacks18 days ago

    Amedisys (AMED) Tops Earnings and Revenue Estimates in Q1

    At Home Health and Hospice divisions, Amedisys (AMED) witnesses solid year-over-year growth in Medicare and non-Medicare revenues.

  • AMEDISYS Inc (AMED) Q1 2019 Earnings Call Transcript
    Motley Fool19 days ago

    AMEDISYS Inc (AMED) Q1 2019 Earnings Call Transcript

    AMED earnings call for the period ending March 31, 2019.

  • Amedisys (AMED) Upgraded to Buy: Here's What You Should Know
    Zacks19 days ago

    Amedisys (AMED) Upgraded to Buy: Here's What You Should Know

    Amedisys (AMED) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  • ACCESSWIRE19 days ago

    Amedisys, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 1, 2019 / Amedisys, Inc. (NASDAQ: AMED ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 1, 2019 at 11:00 AM Eastern Time. ...

  • One Thing To Remember About The Amedisys, Inc. (NASDAQ:AMED) Share Price
    Simply Wall St.19 days ago

    One Thing To Remember About The Amedisys, Inc. (NASDAQ:AMED) Share Price

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! If you own shares in Amedisys, Inc. (NASDAQ:AMED) then it's worth thinking about how it contributes t...

  • Associated Press20 days ago

    Amedisys: 1Q Earnings Snapshot

    The Baton Rouge, Louisiana-based company said it had net income of 95 cents per share. Earnings, adjusted for non-recurring costs, came to $1.11 per share. The results beat Wall Street expectations. The ...

  • GlobeNewswire20 days ago

    Amedisys Reports First Quarter 2019 Financial Results and Reaffirms 2019 Guidance

    BATON ROUGE, La., April 30, 2019 -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2019. Three Month Periods.

  • Zacks.com featured highlights include: Raytheon, Otter, Amedysis, Tutor and DMC
    Zacks21 days ago

    Zacks.com featured highlights include: Raytheon, Otter, Amedysis, Tutor and DMC

    Zacks.com featured highlights include: Raytheon, Otter, Amedysis, Tutor and DMC

  • Amedisys (AMED) is an Incredible Growth Stock: 3 Reasons Why
    Zacks21 days ago

    Amedisys (AMED) is an Incredible Growth Stock: 3 Reasons Why

    Amedisys (AMED) is well positioned to outperform the market, as it exhibits above-average growth in financials.

  • Here’s What Hedge Funds Think About Amedisys Inc (AMED)
    Insider Monkey24 days ago

    Here’s What Hedge Funds Think About Amedisys Inc (AMED)

    Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities over the years (that's why their assets under management continue to swell). We believe hedge fund sentiment should serve as a crucial tool of an […]

  • Buy These 5 Low Leverage Stocks to Avoid Huge Losses
    Zacks24 days ago

    Buy These 5 Low Leverage Stocks to Avoid Huge Losses

    Companies with large debt loads are more vulnerable during economic downturns and can even go bankrupt in the worst-case scenario

  • These 5 Stocks Boast Impressive Interest Coverage Ratio
    Zacks26 days ago

    These 5 Stocks Boast Impressive Interest Coverage Ratio

    Interest Coverage Ratio is used to determine how effectively a company can pay the interest charges on its debt.

  • Amedisys (AMED) Reports Next Week: Wall Street Expects Earnings Growth
    Zacks27 days ago

    Amedisys (AMED) Reports Next Week: Wall Street Expects Earnings Growth

    Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.